These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 19259744)

  • 1. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion.
    Strzelczyk B; Szulc A; Rzepko R; Kitowska A; Skokowski J; Szutowicz A; Pawelczyk T
    Ann Surg Oncol; 2009 May; 16(5):1287-94. PubMed ID: 19259744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
    Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
    Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.
    Song Y; Oda Y; Hori M; Kuroiwa K; Ono M; Hosoi F; Basaki Y; Tokunaga S; Kuwano M; Naito S; Tsuneyoshi M
    Hum Pathol; 2010 Feb; 41(2):214-22. PubMed ID: 19800102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
    Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
    Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.
    Krajewska M; Kim H; Kim C; Kang H; Welsh K; Matsuzawa S; Tsukamoto M; Thomas RG; Assa-Munt N; Piao Z; Suzuki K; Perucho M; Krajewski S; Reed JC
    Clin Cancer Res; 2005 Aug; 11(15):5451-61. PubMed ID: 16061861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulated GAS1 expression correlates with recurrence in stage II and III colorectal cancer.
    Jiang Z; Xu Y; Cai S
    Hum Pathol; 2011 Mar; 42(3):361-8. PubMed ID: 21111449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level of Notch1 protein is associated with poor overall survival in colorectal cancer.
    Chu D; Li Y; Wang W; Zhao Q; Li J; Lu Y; Li M; Dong G; Zhang H; Xie H; Ji G
    Ann Surg Oncol; 2010 May; 17(5):1337-42. PubMed ID: 20058190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
    Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
    Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
    Zlobec I; Baker K; Minoo P; Hayashi S; Terracciano L; Lugli A
    Cancer; 2009 Sep; 115(17):4021-9. PubMed ID: 19517467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
    J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis.
    Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S
    J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
    Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
    J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic loss of chromosome 18q and prognosis in colorectal cancer.
    Jen J; Kim H; Piantadosi S; Liu ZF; Levitt RC; Sistonen P; Kinzler KW; Vogelstein B; Hamilton SR
    N Engl J Med; 1994 Jul; 331(4):213-21. PubMed ID: 8015568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
    Yamamoto H; Iku S; Adachi Y; Imsumran A; Taniguchi H; Nosho K; Min Y; Horiuchi S; Yoshida M; Itoh F; Imai K
    J Pathol; 2003 Feb; 199(2):176-84. PubMed ID: 12533830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DCC protein and prognosis in colorectal cancer.
    Shibata D; Reale MA; Lavin P; Silverman M; Fearon ER; Steele G; Jessup JM; Loda M; Summerhayes IC
    N Engl J Med; 1996 Dec; 335(23):1727-32. PubMed ID: 8929264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.